prednisone has been researched along with ATLL in 80 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lamivudine was administered for prevention of chemotherapy induced HBV reactivation." | 5.33 | [Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy]. ( Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T, 2006) |
| "During treatment Hepatitis B was reactivated and after termination, of chemotherapy she developed fulminant hepatitis with hyperbilirubinemia, coagulopathy, hypoalbuminemia and ascites." | 5.31 | [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration]. ( Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M, 2001) |
| "Our previous phase II trial for treating human T-lymphotropic virus type I-associated adult T-cell leukemia-lymphoma (ATLL) with vincristine, cyclophosphamide, doxorubicin, and prednisone (VCAP), doxorubicin, ranimustine, and prednisone (AMP), and vindesine, etoposide, carboplatin, and prednisone (VECP) showed promising results." | 5.12 | VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. ( Fukuda, H; Fukushima, T; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Masuda, M; Momita, S; Nagoshi, H; Sano, M; Shibata, T; Shimoyama, M; Takatsuka, Y; Tamura, K; Tobinai, K; Tomonaga, M; Tsukasaki, K; Ueda, R; Utsunomiya, A; Yamaguchi, K, 2007) |
| " A laparotomy revealed multiple granulomas containing Fusarium sp." | 4.78 | Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. ( Amselem, S; Ben-Yehuda, D; Eldor, A; Engelhard, D; Hardan, I; Lopez-Berestein, G; Polacheck, I; Rachmilewitz, EA; Sacks, T; Salkin, IF, 1993) |
| "We present 10 patients with acute and lymphomatous subtypes of ATLL treated with distinct induction regimens, including CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine [Oncovin], prednisone or prednisolone), interferon/zidovudine, and VCAP-AMP-VECP (vincristine, cyclophosphamide, doxorubicin, prednisone; doxorubicin, ranimustine, prednisone; vindesine, etoposide, carboplatin, prednisone)." | 3.83 | Adult T-Cell Leukemia/Lymphoma: Rarely Encountered in the United States. ( Komrokji, R; Price, S; Roe, C; Sokol, L; Zhang, L, 2016) |
| " From these clinical and laboratory data, the patient was diagnosed as having B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS) and treated with R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone)." | 3.78 | [Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome]. ( Fujishima, N; Guo, YM; Hirokawa, M; Ito, M; Kameoka, Y; Nagao, T; Noguchi, S; Saitoh, H; Sawada, K; Tagawa, H; Takahashi, N; Watanabe, A, 2012) |
| "Adult T-cell leukaemia lymphoma (ATLL) is an aggressive T-cell malignancy caused by the human T-lymphotropic virus type-1 (HTLV-1) and is associated with a very poor prognosis." | 2.77 | Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL). ( Cavenagh, J; Ceesay, MM; Devereux, S; Fields, P; Ho, A; Matutes, E; Mufti, GJ; Pagliuca, A; Simpson, S; Taylor, GP, 2012) |
| "Testicular recurrence varied from 2-8% in comparison with 20% in the historic group." | 2.69 | Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group. ( Bleyer, WA; Breneman, JC; Cherlow, JM; Gaynon, PS; Grossman, NJ; Johnstone, HS; Kersey, JH; Sather, HN; Steinherz, PG; Trigg, ME; Uckun, FM, 1998) |
| "Twenty-one patients (ALL:10, NHL:8, ATLL:2, ATL:1) were assessable for response and toxicity." | 2.69 | [EPOCH therapy for relapsed/refractory lymphoid malignancies]. ( Asai, O; Dobashi, N; Kato, A; Katori, M; Kobayashi, T; Kuraishi, Y; Nagamine, M; Tajima, N; Usui, N; Watanabe, H; Yamazaki, H; Yano, S, 1998) |
| "Adult T-cell leukemia lymphoma (ATLL) is an aggressive mature T-cell neoplasm caused by human T-cell lymphotropic virus type 1 (HTLV-1) infection." | 1.91 | Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers. ( Boisclair, S; Brahim, A; Bridgellal, S; Castillo-Tokumori, F; Dong, N; Pullukkara, JJ; Saeed, H; Sandoval-Sus, J; Sokol, L; Walker, D; Zhang, L, 2023) |
| "Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell neoplasm caused by the human T-cell leukemia virus type 1 (HTLV-1)." | 1.56 | Case Report: An Uncommon Clinical Case of Fatal Adult T-Cell Leukemia/Lymphoma Associated with HTLV-1 and Suspected due to Cutaneous Lesions and Epidemiologic Data. ( Carvalho de Assis, I; Criado, PR; Rodrigues Alberti, JG, 2020) |
| "Adult T-cell leukemia/lymphoma (ATLL) is a relatively refractory CD4-positive peripheral T-cell lymphoma." | 1.56 | Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma. ( Abe, K; Hayashi, S; Jo, T; Kaneko, Y; Kubota-Koketsu, R; Matsuo, M; Matsuzaka, K; Sakai, T; Shigematsu, K; Shioya, H; Taguchi, J; Tominaga, H, 2020) |
| "The rarity of adult T cell leukemia/lymphoma (ATLL) in China, coupled with its clinicopathologic mimicry of primary skin disease, poses a diagnostic challenge." | 1.56 | Cutaneous plaque in adult T cell leukemia/lymphoma: A case report. ( Jiang, Q; Lei, CS; Qiu, L; Yu, Q, 2020) |
| "Adult T-cell leukaemia-lymphoma (ATLL) is a peripheral T-cell leukaemia-lymphoma caused by the retrovirus, human T-cell lymphotropic virus 1 (HTLV-1)." | 1.51 | Bowenoid papulosis unveiling a rare cause of immunosuppression. ( Ambooken, B; Asokan, N; Jisha, KT; Philip, P, 2019) |
| "Adult T-cell Leukemia/Lymphoma (ATLL) is classified as a peripheral CD4+ T-cell neoplasm caused by the human T-cell lymphotropic virus type 1 (HTLV-1)." | 1.46 | Comorbidity between HTLV-1-associated adult T-cell lymphoma/leukemia and verrucous carcinoma: a case report. ( Moreno, L; Valencia, M, 2017) |
| "Adult T-cell leukaemia/lymphoma (ATLL) is a rare mature T-cell malignancy that occurs in patients infected with human T-cell leukaemia virus type 1 (HTLV-1)." | 1.43 | [Leukocytosis and skin lesions: consider malignancy; adult T-cell leukaemia/lymphoma]. ( Lam, KH; Langerak, AW; Rijneveld, AW; Sandberg, Y; van Lom, K, 2016) |
| "Notably, septic lymphadenitis is pivotal in the differential diagnosis of systemic lymphadenopathy in ATL." | 1.42 | Giant Septic Lymphadenitis with Marked Gas Formation Caused by Bacteroides fragilis in a Patient with Adult T-cell Leukemia/lymphoma. ( Fukushima, T; Hanashiro, T; Masuzaki, H; Morichika, K; Nakachi, S; Nishi, Y; Samura, H; Shimabukuro, N; Tamaki, K; Tedokon, I; Tomoyose, T, 2015) |
| "The reason why CHOP-resistant ATLL responded dramatically to SBZ alone is not clear, but the plasma concentration of the metabolite of SBZ was possibly very high because of renal failure." | 1.36 | [Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone]. ( Murotani, N; Sakai, C, 2010) |
| " Dosage was split with 18 mg given at breakfast and 18 mg zinc with supper." | 1.33 | Treatment of acute lymphocytic leukemia using zinc adjuvant with chemotherapy and radiation--a case history and hypothesis. ( Eby, GA, 2005) |
| "Adult T-cell leukemia/lymphoma (ATLL) is a malignant proliferation of mature helper T lymphocytes,(1) and is caused by human T-lymphotropic virus type I (HTLV-I);(2) an HTLV-I infection endemic in the Caribbean, south-western Japan, South America and Africa." | 1.33 | Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma. ( Almeida, FA; Chiba, AK; Colleoni, GW; Fernandes, MA; Michalany, NS; Petri, V; Pombo-de-Oliveira, MS; Sakamoto, FH; Teixeira, SP; Yamamoto, M, 2006) |
| "Lamivudine was administered for prevention of chemotherapy induced HBV reactivation." | 1.33 | [Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy]. ( Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T, 2006) |
| "Adult T-cell leukemia-lymphoma (ATLL) has a very bad prognosis and remains resistant to conventional therapy." | 1.31 | Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide. ( Besson, C; Brebion, A; Delaunay, C; Gonin, C; Hermine, O; Panelatti, G; Plumelle, Y, 2002) |
| "During treatment Hepatitis B was reactivated and after termination, of chemotherapy she developed fulminant hepatitis with hyperbilirubinemia, coagulopathy, hypoalbuminemia and ascites." | 1.31 | [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration]. ( Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M, 2001) |
| "All cases with lymphadenitis were still alive at the end of the study, while survival progressively decreased in the Hodgkin's type." | 1.30 | Survival of patients with HTLV-I-associated lymph node lesions. ( Haraoka, S; Kanda, M; Kawasaki, C; Kikuchi, M; Ohshima, K; Sato, K; Simazaki, T; Suzumiya, J, 1999) |
| "prototypic ATLL." | 1.29 | Adult T-cell leukemia/lymphoma in a Korean--a case report. ( Hong, SI; Jang, JJ; Kang, YK; Kim, CW; Lee, DS; Lee, SS, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.25) | 18.7374 |
| 1990's | 23 (28.75) | 18.2507 |
| 2000's | 23 (28.75) | 29.6817 |
| 2010's | 23 (28.75) | 24.3611 |
| 2020's | 10 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenthal, R | 1 |
| Kaplan, J | 1 |
| Ahmed, M | 1 |
| Mims, M | 1 |
| Weatherhead, JE | 1 |
| Saeed, H | 1 |
| Sandoval-Sus, J | 1 |
| Castillo-Tokumori, F | 1 |
| Dong, N | 1 |
| Pullukkara, JJ | 1 |
| Boisclair, S | 1 |
| Brahim, A | 1 |
| Walker, D | 1 |
| Bridgellal, S | 1 |
| Zhang, L | 2 |
| Sokol, L | 2 |
| Mendonca Bryne, S | 1 |
| Hanaganahalli Basavaiah, S | 1 |
| Christina Pinto, A | 1 |
| Bhat, G | 1 |
| Upadyaya, K | 1 |
| Thahir, M | 1 |
| Carvalho de Assis, I | 1 |
| Rodrigues Alberti, JG | 1 |
| Criado, PR | 1 |
| Farina, K | 1 |
| Kalac, M | 1 |
| Kim, S | 2 |
| Jo, T | 1 |
| Matsuzaka, K | 1 |
| Shioya, H | 1 |
| Tominaga, H | 1 |
| Sakai, T | 1 |
| Kaneko, Y | 1 |
| Hayashi, S | 1 |
| Matsuo, M | 1 |
| Taguchi, J | 3 |
| Abe, K | 1 |
| Shigematsu, K | 1 |
| Kubota-Koketsu, R | 1 |
| Imaizumi, Y | 3 |
| Iwanaga, M | 1 |
| Nosaka, K | 1 |
| Ishitsuka, K | 1 |
| Ishizawa, K | 1 |
| Ito, S | 1 |
| Amano, M | 1 |
| Ishida, T | 3 |
| Uike, N | 1 |
| Utsunomiya, A | 5 |
| Ohshima, K | 2 |
| Tanaka, J | 1 |
| Tokura, Y | 1 |
| Tobinai, K | 4 |
| Watanabe, T | 1 |
| Uchimaru, K | 2 |
| Tsukasaki, K | 4 |
| Cook, LB | 1 |
| Phillips, AA | 1 |
| Lei, CS | 1 |
| Jiang, Q | 1 |
| Yu, Q | 1 |
| Qiu, L | 1 |
| Sakamoto, Y | 1 |
| Masaki, A | 1 |
| Murase, T | 1 |
| Takeshita, M | 1 |
| Muto, R | 1 |
| Iwasaki, H | 1 |
| Ito, A | 1 |
| Kusumoto, S | 1 |
| Nakano, N | 1 |
| Tokunaga, M | 1 |
| Yonekura, K | 1 |
| Tashiro, Y | 1 |
| Iida, S | 1 |
| Ueda, R | 2 |
| Inagaki, H | 1 |
| Valencia, M | 1 |
| Moreno, L | 1 |
| Mehta-Shah, N | 1 |
| Ratner, L | 2 |
| Horwitz, SM | 1 |
| Toriyama, E | 1 |
| Taniguchi, H | 2 |
| Nakashima, J | 1 |
| Itonaga, H | 1 |
| Sato, S | 1 |
| Ando, K | 1 |
| Sawayama, Y | 2 |
| Hata, T | 2 |
| Fukushima, T | 5 |
| Miyazaki, Y | 2 |
| Sueda, S | 1 |
| Nakayama, S | 1 |
| Adachi, T | 1 |
| Ohashi, Y | 1 |
| Awaji, S | 1 |
| Hashimoto, S | 1 |
| Matsumura, I | 1 |
| Matsuda, M | 1 |
| Ambooken, B | 1 |
| Asokan, N | 1 |
| Philip, P | 1 |
| Jisha, KT | 1 |
| Ohno, N | 1 |
| Kobayashi, S | 1 |
| Ishigaki, T | 1 |
| Yuji, K | 1 |
| Kobayashi, M | 1 |
| Sato, K | 2 |
| Watanabe, N | 1 |
| Tojo, A | 1 |
| Kato, K | 1 |
| Makiyama, J | 1 |
| Tsushima, H | 1 |
| Moriwaki, Y | 1 |
| Imanishi, D | 1 |
| Kawano, N | 1 |
| Yoshida, S | 1 |
| Kuriyama, T | 1 |
| Tahara, Y | 1 |
| Yamashita, K | 1 |
| Nagahiro, Y | 1 |
| Kawano, J | 1 |
| Koketsu, H | 1 |
| Toyofuku, A | 1 |
| Manabe, T | 1 |
| Beppu, K | 1 |
| Ono, N | 1 |
| Himeji, D | 1 |
| Yokota-Ikeda, N | 1 |
| Inoue, S | 1 |
| Ochiai, H | 1 |
| Sonoda, KH | 1 |
| Shimoda, K | 1 |
| Ishikawa, F | 1 |
| Ueda, A | 1 |
| Tomoyose, T | 3 |
| Nakachi, S | 3 |
| Nishi, Y | 2 |
| Morichika, K | 2 |
| Tedokon, I | 2 |
| Tamaki, K | 3 |
| Shimabukuro, N | 2 |
| Hanashiro, T | 1 |
| Samura, H | 1 |
| Masuzaki, H | 2 |
| Ureshino, H | 1 |
| Miyahara, M | 1 |
| Rauch, D | 1 |
| Abel, H | 1 |
| Caruso, B | 1 |
| Noy, A | 1 |
| Barta, SK | 1 |
| Parekh, S | 1 |
| Ramos, JC | 1 |
| Ambinder, R | 1 |
| Phillips, A | 1 |
| Harding, J | 1 |
| Baydoun, HH | 1 |
| Cheng, X | 1 |
| Jacobson, S | 1 |
| Sandberg, Y | 1 |
| Langerak, AW | 1 |
| Lam, KH | 1 |
| Rijneveld, AW | 1 |
| van Lom, K | 1 |
| Ogura, M | 1 |
| Takahashi, T | 2 |
| Nomura, S | 1 |
| Taira, N | 2 |
| Miyagi, T | 2 |
| Karimata, K | 1 |
| Ohama, M | 1 |
| Yamanoha, A | 1 |
| Hayashi, M | 1 |
| Arakaki, H | 1 |
| Uchihara, JN | 1 |
| Ohshiro, K | 1 |
| Asakura, Y | 1 |
| Kuba-Miyara, M | 1 |
| Karube, K | 1 |
| Roe, C | 1 |
| Komrokji, R | 1 |
| Price, S | 1 |
| Bittencourt, AL | 2 |
| Barbosa, HS | 1 |
| Pimenta, A | 1 |
| Farre, L | 2 |
| Oono, S | 1 |
| Kurimoto, T | 1 |
| Oku, H | 1 |
| Mimura, O | 1 |
| Marneros, AG | 1 |
| Grossman, ME | 2 |
| Silvers, DN | 1 |
| Husain, S | 1 |
| Nuovo, GJ | 1 |
| MacGregor-Cortelli, B | 1 |
| Neylon, E | 1 |
| Patterson, M | 1 |
| O'Connor, OA | 1 |
| Zain, JM | 1 |
| Fritsch-Stork, RD | 1 |
| Leguit, RJ | 1 |
| Derksen, RH | 1 |
| Hoshi, M | 1 |
| Ito, H | 1 |
| Fujigaki, H | 1 |
| Takemura, M | 1 |
| Tomita, E | 1 |
| Ohyama, M | 1 |
| Tanaka, R | 1 |
| Ohtaki, H | 1 |
| Saito, K | 1 |
| Seishima, M | 1 |
| Mota, K | 1 |
| Oliveira, RF | 1 |
| Sakai, C | 1 |
| Murotani, N | 1 |
| Grubb, B | 1 |
| Henderson, DB | 1 |
| Pandya, AG | 1 |
| Ceesay, MM | 1 |
| Matutes, E | 2 |
| Taylor, GP | 1 |
| Fields, P | 1 |
| Cavenagh, J | 1 |
| Simpson, S | 1 |
| Ho, A | 1 |
| Devereux, S | 1 |
| Mufti, GJ | 1 |
| Pagliuca, A | 1 |
| Larson, TA | 1 |
| Hu, M | 1 |
| Janik, JE | 1 |
| Nussenblatt, RB | 1 |
| Morris, JC | 1 |
| Sen, HN | 1 |
| Terada, T | 1 |
| Shirakashi, Y | 1 |
| Sugiura, M | 1 |
| Nagao, T | 1 |
| Takahashi, N | 1 |
| Saitoh, H | 1 |
| Noguchi, S | 1 |
| Guo, YM | 1 |
| Ito, M | 1 |
| Watanabe, A | 1 |
| Fujishima, N | 1 |
| Kameoka, Y | 1 |
| Tagawa, H | 1 |
| Hirokawa, M | 1 |
| Sawada, K | 1 |
| Hamaad, A | 1 |
| Davis, RC | 1 |
| Connolly, DL | 1 |
| Besson, C | 1 |
| Panelatti, G | 1 |
| Delaunay, C | 1 |
| Gonin, C | 1 |
| Brebion, A | 1 |
| Hermine, O | 1 |
| Plumelle, Y | 1 |
| Le Gouill, S | 1 |
| Lepretre, S | 1 |
| Brière, J | 1 |
| Morel, P | 1 |
| Bouabdallah, R | 1 |
| Raffoux, E | 1 |
| Sebban, C | 1 |
| Lepage, E | 1 |
| Brice, P | 1 |
| Mori, A | 1 |
| Kikuchi, Y | 1 |
| Motoori, S | 1 |
| Watanabe, J | 1 |
| Shinozaki, M | 1 |
| Eguchi, M | 1 |
| Tong, GX | 1 |
| Hernandez, O | 1 |
| Yee, HT | 1 |
| Zheng, SH | 1 |
| Yang, GC | 1 |
| Eby, GA | 1 |
| Hara, S | 1 |
| Yokote, T | 1 |
| Akioka, T | 1 |
| Oka, S | 1 |
| Yamano, T | 1 |
| Tsuji, M | 1 |
| Hanafusa, T | 2 |
| Abla, O | 1 |
| Gassas, A | 1 |
| Stevens, R | 1 |
| Grant, R | 1 |
| Abdelhaleem, M | 1 |
| Sakamoto, FH | 1 |
| Colleoni, GW | 1 |
| Teixeira, SP | 1 |
| Yamamoto, M | 1 |
| Michalany, NS | 1 |
| Almeida, FA | 1 |
| Chiba, AK | 1 |
| Petri, V | 1 |
| Fernandes, MA | 1 |
| Pombo-de-Oliveira, MS | 1 |
| Nagasaki, A | 1 |
| Shinzato, O | 1 |
| Hasegawa, H | 1 |
| Takasu, N | 1 |
| Fukuda, H | 2 |
| Shibata, T | 1 |
| Takatsuka, Y | 1 |
| Ikeda, S | 3 |
| Masuda, M | 1 |
| Nagoshi, H | 1 |
| Tamura, K | 2 |
| Sano, M | 2 |
| Momita, S | 2 |
| Yamaguchi, K | 1 |
| Kawano, F | 3 |
| Hanada, S | 2 |
| Shimoyama, M | 3 |
| Hotta, T | 2 |
| Tomonaga, M | 3 |
| Nagatani, T | 1 |
| Miyazawa, M | 1 |
| Matsuzaki, T | 1 |
| Iemoto, G | 1 |
| Baba, N | 1 |
| Miyakawa, K | 1 |
| Miyamoto, H | 1 |
| Nakajima, H | 1 |
| Hirai, Y | 1 |
| Lee, SS | 1 |
| Hong, SI | 1 |
| Lee, DS | 1 |
| Kang, YK | 1 |
| Kim, CW | 1 |
| Jang, JJ | 1 |
| Digel, W | 1 |
| Schultze, J | 1 |
| Kunzmann, R | 1 |
| Mertelsmann, R | 1 |
| Lindemann, A | 1 |
| Kudva, GC | 1 |
| Chandy, M | 1 |
| Dennison, D | 1 |
| Srivastava, A | 1 |
| Bhushan, V | 1 |
| Bain, B | 1 |
| Catovsky, D | 1 |
| Engelhard, D | 1 |
| Eldor, A | 1 |
| Polacheck, I | 1 |
| Hardan, I | 1 |
| Ben-Yehuda, D | 1 |
| Amselem, S | 1 |
| Salkin, IF | 1 |
| Lopez-Berestein, G | 1 |
| Sacks, T | 1 |
| Rachmilewitz, EA | 1 |
| Tong, MK | 1 |
| Wolf, M | 1 |
| Juneja, S | 1 |
| Hayashi, T | 1 |
| Yamabe, H | 1 |
| Haga, H | 1 |
| Akasaka, T | 1 |
| Kadowaki, N | 1 |
| Ohno, H | 1 |
| Okuma, M | 1 |
| Fukuhara, S | 1 |
| Taguchi, H | 1 |
| Kinoshita, KI | 1 |
| Takatsuki, K | 3 |
| Araki, K | 2 |
| Arima, N | 1 |
| Uozumi, K | 1 |
| Kohno, H | 1 |
| Kikuchi, H | 1 |
| Takahashi, H | 1 |
| Chiyoda, S | 1 |
| Tsuda, H | 1 |
| Nishimura, H | 1 |
| Hosokawa, T | 1 |
| Matsuzaki, H | 1 |
| Yamada, O | 1 |
| Miyoshi, I | 1 |
| Hiroyasu, S | 1 |
| Shiraishi, M | 1 |
| Shimabukuro, M | 1 |
| Kusano, T | 1 |
| Muto, Y | 1 |
| Dibenedetto, SP | 1 |
| Lo Nigro, L | 1 |
| Mayer, SP | 1 |
| Rovera, G | 1 |
| Schilirò, G | 1 |
| Conter, V | 1 |
| Schrappe, M | 1 |
| Aricó, M | 1 |
| Reiter, A | 1 |
| Rizzari, C | 1 |
| Dördelmann, M | 1 |
| Valsecchi, MG | 1 |
| Zimmermann, M | 1 |
| Ludwig, WD | 1 |
| Basso, G | 1 |
| Masera, G | 1 |
| Riehm, H | 1 |
| Steinherz, PG | 1 |
| Gaynon, PS | 1 |
| Breneman, JC | 1 |
| Cherlow, JM | 1 |
| Grossman, NJ | 1 |
| Kersey, JH | 1 |
| Johnstone, HS | 1 |
| Sather, HN | 1 |
| Trigg, ME | 1 |
| Uckun, FM | 1 |
| Bleyer, WA | 1 |
| Lenormand, B | 1 |
| Béné, MC | 1 |
| Lesesve, JF | 1 |
| Bastard, C | 1 |
| Tilly, H | 1 |
| Lefranc, MP | 1 |
| Faure, GC | 1 |
| Garand, R | 1 |
| Falkenrodt, A | 1 |
| Kandel, G | 1 |
| Solary, E | 1 |
| Maynadié, M | 1 |
| Callat, MP | 1 |
| Thouret, F | 1 |
| Monconduit, M | 1 |
| Vannier, JP | 1 |
| Tamiya, S | 1 |
| Etoh, K | 1 |
| Suzushima, H | 1 |
| Matsuoka, M | 1 |
| Dobashi, N | 1 |
| Usui, N | 1 |
| Kobayashi, T | 1 |
| Yamazaki, H | 1 |
| Asai, O | 1 |
| Yano, S | 1 |
| Kato, A | 1 |
| Watanabe, H | 1 |
| Nagamine, M | 1 |
| Katori, M | 1 |
| Tajima, N | 1 |
| Kuraishi, Y | 1 |
| Suzumiya, J | 1 |
| Kanda, M | 1 |
| Simazaki, T | 1 |
| Kawasaki, C | 1 |
| Haraoka, S | 1 |
| Kikuchi, M | 1 |
| Griffin, TC | 1 |
| Shuster, JJ | 2 |
| Buchanan, GR | 1 |
| Murphy, SB | 1 |
| Camitta, BM | 1 |
| Amylon, MD | 1 |
| Ichikawa, Y | 1 |
| Iida, M | 1 |
| Ebisui, C | 1 |
| Fujio, C | 1 |
| Yazawa, K | 1 |
| Kouro, T | 1 |
| Seki, K | 1 |
| Nagano, S | 1 |
| Fassas, AB | 1 |
| Rapoport, AP | 1 |
| Cottler-Fox, M | 1 |
| Chen, T | 1 |
| Tricot, G | 1 |
| Yamada, Y | 1 |
| Tara, M | 1 |
| Kozuru, M | 1 |
| Niimi, M | 1 |
| Shtalrid, M | 1 |
| Haran, M | 1 |
| Klepfish, A | 1 |
| Lurie, Y | 1 |
| Malnick, S | 1 |
| Michael, EJ | 1 |
| Shaffer, JJ | 1 |
| Collins, HE | 1 |
| Crist, W | 1 |
| Shuster, J | 1 |
| Look, T | 1 |
| Borowitz, M | 1 |
| Behm, F | 1 |
| Bowman, P | 1 |
| Frankel, L | 1 |
| Pullen, J | 1 |
| Krance, R | 1 |
| Steuber, P | 1 |
| Falletta, JM | 1 |
| Crist, WM | 1 |
| Pullen, DJ | 1 |
| Borowitz, MJ | 1 |
| Wharam, M | 1 |
| Patterson, R | 1 |
| Foreman, E | 1 |
| Vietti, TJ | 1 |
| Rio, B | 1 |
| Louvet, C | 1 |
| Gessain, A | 1 |
| Dormont, D | 1 |
| Gisselbrecht, C | 1 |
| Martoia, R | 1 |
| Auzanneau, G | 1 |
| Miclea, JM | 1 |
| Baumelou, E | 1 |
| Dombret, H | 1 |
| Akiba, M | 1 |
| Kunieda, Y | 1 |
| Maeda, S | 1 |
| Oita, M | 1 |
| Okabe, M | 1 |
| Maekawa, I | 1 |
| Miyazaki, T | 1 |
| Kowal-Vern, A | 1 |
| Melnyk, A | 1 |
| Bradstock, KF | 1 |
| Koutts, J | 1 |
| Stanton, A | 1 |
| Lee, CH | 1 |
| Robertson, TI | 1 |
| Castaldi, P | 1 |
| Kamath, S | 1 |
| Carter, J | 1 |
| Greenberg, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma[NCT05996185] | Phase 2 | 36 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | ||
| A Multicenter, Phase 2 Study, to Evaluate Safety and Efficacy of an Acute Lymphoblastic Leukemia (ALL) Intensive Chemotherapy for Adult Lymphoblastic Lymphoma (LL).[NCT00195871] | Phase 2 | 155 participants (Actual) | Interventional | 2004-02-29 | Active, not recruiting | ||
| A Phase II Study of Daratumumab-Hyaluronidase for Chemotherapy-Relapsed/Refractory Minimal Residual Disease (MRD) in T Cell Acute Lymphoblastic Leukemia (T-ALL[NCT05289687] | Phase 2 | 20 participants (Anticipated) | Interventional | 2023-05-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for prednisone and ATLL
| Article | Year |
|---|---|
Adult T-Cell Leukemia/Lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; | 2017 |
[Malignant lymphoma and adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidi | 2014 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleom | 2014 |
[Recent progress in the treatment of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1994 |
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; D | 1993 |
[Adult T-cell leukemia and non-malignant adenopathies associated with HTLV I virus. Apropos of 17 patients born in the Caribbean region and Africa].
Topics: Adult; Africa; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclopho | 1990 |
[Tumor lysis syndrome at the induction therapy of the first remission in two cases of T-ALL].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Leukemia-Lym | 1990 |
11 trials available for prednisone and ATLL
| Article | Year |
|---|---|
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Comb | 2012 |
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubi | 2007 |
An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Cyclopho | 1996 |
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc | 1998 |
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies.
Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bur | 1998 |
[EPOCH therapy for relapsed/refractory lymphoid malignancies].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dr | 1998 |
Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Confi | 2000 |
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubi | 2001 |
Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymph | 1992 |
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous Sys | 1992 |
[Adult T-cell leukemia and non-malignant adenopathies associated with HTLV I virus. Apropos of 17 patients born in the Caribbean region and Africa].
Topics: Adult; Africa; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclopho | 1990 |
63 other studies available for prednisone and ATLL
| Article | Year |
|---|---|
Case Report: HTLV-1-Induced Adult T-Cell Leukemia and Tropical Spastic Paresis.
Topics: Antiviral Agents; Human T-lymphotropic virus 1; Humans; Iran; Leukemia-Lymphoma, Adult T-Cell; Male; | 2021 |
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukem | 2023 |
An Unusual Presentation of HTLV-Associated Adult T-Cell Lymphoma/Leukemia - An Eye That Said It "A (T) LL".
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Human T-lymphotr | 2020 |
Case Report: An Uncommon Clinical Case of Fatal Adult T-Cell Leukemia/Lymphoma Associated with HTLV-1 and Suspected due to Cutaneous Lesions and Epidemiologic Data.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female | 2020 |
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; C | 2021 |
Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro | 2020 |
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cycl | 2020 |
How I treat adult T-cell leukemia/lymphoma.
Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineopl | 2021 |
Cutaneous plaque in adult T cell leukemia/lymphoma: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2020 |
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combin | 2021 |
Comorbidity between HTLV-1-associated adult T-cell lymphoma/leukemia and verrucous carcinoma: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Verrucous; CD4-Positive T-Lymphocytes; Cy | 2017 |
EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.
Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2018 |
Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CTLA-4 Antigen; Cyclophosphamide; Doxorubicin; | 2019 |
Bowenoid papulosis unveiling a rare cause of immunosuppression.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Condylomata Acumina | 2019 |
Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisp | 2013 |
Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 2014 |
Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxoru | 2015 |
Giant Septic Lymphadenitis with Marked Gas Formation Caused by Bacteroides fragilis in a Patient with Adult T-cell Leukemia/lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteroides fragilis; Bacteroides Infections; | 2015 |
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carb | 2016 |
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide | 2016 |
[Leukocytosis and skin lesions: consider malignancy; adult T-cell leukaemia/lymphoma].
Topics: Antiviral Agents; Cyclophosphamide; Doxorubicin; Human T-lymphotropic virus 1; Humans; Leukemia-Lymp | 2016 |
Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cycl | 2016 |
Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; | 2016 |
Adult T-Cell Leukemia/Lymphoma: Rarely Encountered in the United States.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Cells; Cyclophosphami | 2016 |
A case of adult T-cell leukemia/lymphoma (ATL) with a survival of more than 13 years.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubic | 2008 |
Adult T-cell leukemia presenting with episcleritis and secondary glaucoma.
Topics: Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Conjunctivit | 2009 |
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.
Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; | 2009 |
Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE.
Topics: Azathioprine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Gluco | 2009 |
Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Dr | 2009 |
A dyshidrosis-like variant of adult T-cell leukemia/lymphoma with clinicopathological aspects of mycosis fungoides. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diabetes Mellitus; Diagnosi | 2009 |
[Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance | 2010 |
Adult T-cell lymphoma/leukemia presenting as pagetoid reticulosis of the palms and soles.
Topics: Adult; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclophosph | 2011 |
Interleukin-2 receptor targeted therapy of ocular disease of HTLV-1-associated adult T-cell leukemia.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemot | 2012 |
T-cell lymphoma of the penis as the first manifestation of adult T-cell lymphoma/leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 2012 |
[Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2012 |
Regression of HTLV1 associated intracardiac lymphoma following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide | 2002 |
Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Dox | 2002 |
Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trial | 2003 |
Acute pancreatitis induced by diffuse pancreatic invasion of adult T-cell leukemia/lymphoma cells.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cholangiopancreatogra | 2003 |
Human T-lymphotropic virus type-1 related adult T-cell leukemia/lymphoma presenting as a parotid mass diagnosed by fine-needle aspiration biopsy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Cyclophosphamide; Diagnosis, Di | 2004 |
Treatment of acute lymphocytic leukemia using zinc adjuvant with chemotherapy and radiation--a case history and hypothesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy, Adjuvant; Chickenpox Vacc | 2005 |
[Graft-versus-ATLL effect induced by abrupt discontinuation of immunosuppression following allogeneic bone marrow transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Cyclo | 2005 |
bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cerebral Hemo | 2006 |
Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cyclophosphami | 2006 |
[Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carrier State; CD8-Po | 2006 |
Successful treatment of adult T-cell leukemia/lymphoma with MACOP-B, M-FEPA and VEPP-B combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Le | 1993 |
Adult T-cell leukemia/lymphoma in a Korean--a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide | 1994 |
Poor prognosis of prethymic phenotype acute lymphoblastic leukemia (pre-T-ALL).
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cy | 1994 |
Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymph | 1994 |
Teaching cases from the Royal Marsden Hospital. Case 8: a Japanese patient with leukaemia and headache.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Headache; Hum | 1993 |
Adult T cell leukaemia lymphoma in a non-aboriginal Australian woman with no apparent risk factors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Australia; Cyclophosphamide; Doxorubicin; Fem | 1993 |
Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazi | 1995 |
Adult T-cell leukemia/lymphoma with a giant gastric tumor: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1996 |
Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Blottin | 1997 |
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combine | 1997 |
Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Topics: Adult; Aged; Alleles; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Apoptosis; Cy | 1998 |
Survival of patients with HTLV-I-associated lymph node lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Doxorubicin; Hodgkin Di | 1999 |
A case study of adult T-cell lymphoma in a kidney transplant patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 2000 |
Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Female; Follow-Up Studies; Glucocorticoids; Graft | 2000 |
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxo | 2001 |
Bullous adult T-cell lymphoma/leukemia and human T-cell lymphotropic virus-1 associated myelopathy in a 60-year-old man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Doxorubicin; Fatal | 2002 |
T-cell acute lymphoblastic leukemia with t(1;18)(p36;q22).
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chromosome Aberrations; Chromos | 1990 |
Improved treatment results for lymphoblastic lymphoma in adolescents and adults using a doxorubicin-based (APO) protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Doxorubicin; Drug A | 1988 |